Old Web
English
Sign In
Acemap
>
authorDetail
>
David J. Gnarra
David J. Gnarra
Boston Children's Hospital
Immunology
Medicine
Romiplostim
Off-label use
Placebo
4
Papers
72
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Long-Term Use of Open-Label Romiplostim in Children with Chronic/Refractory Immune Thrombocytopenia (ITP)
2012
Blood
James B. Bussel
George R. Buchanan
David J. Gnarra
Richard Ho
Kun Nie
Melissa Eisen
Show All
Source
Cite
Save
Citations (0)
A Randomized, Double-Blind, Placebo-Controlled Phase 1/2 Study to Determine the Safety and Efficacy of Romiplostim in Children with Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP).
2009
Blood
George R. Buchanan
Lisa Bomgaars
James B. Bussel
Diane J. Nugent
David J. Gnarra
Victor S. Blanchette
Kun Nie
Melissa Eisen
Dietmar Berger
Show All
Source
Cite
Save
Citations (7)
Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS)
2009
Pediatric Blood & Cancer
V. Koneti Rao
Susan Price
Katie Perkins
Patricia Aldridge
Jean Tretler
Joie Davis
Janet K. Dale
Fred Gill
Kip R. Hartman
Linda C. Stork
David J. Gnarra
Lakshmanan Krishnamurti
Peter E. Newburger
Jennifer M. Puck
Thomas A. Fleisher
Show All
Source
Cite
Save
Citations (64)
Use of Rituximab for Refractory Immune Cytopenias Associated with Autoimmune Lymphoproliferative Syndrome (ALPS).
2007
Blood
Janet K. Dale
Susan Price
Jean Tretler
Patricia Aldridge
Stephanie Montague
Joie Davis
Fred Gill
Kip R. Hartman
Linda C. Stork
David J. Gnarra
Lakshmanan Krishnamurti
Jennifer M. Puck
Thomas A. Fleisher
V. Koneti Rao
Show All
Source
Cite
Save
Citations (1)
1